In this episode, Dr. Sherer discusses results from key studies reported at the 2020 International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2020 Virtual), including studies on long-term 2-drug and 3-drug antiretroviral therapy, newer 3-drug regimens in patients with baseline NRTI resistance, investigational HIV treatment approaches, and important comoribidities in patients with HIV, including COVID-19.Presenter:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineUniversity of ChicagoChicago, IllinoisContent based on a CME program supported by independent educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare.Link to full program:https://bit.ly/35nGqph Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related